| 8302 | N | 050141 | 001 | PENICILLIN G BENZATHINE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | BICILLIN L-A | KING PHARMS LLC | 600,000 UNITS/ML | BC | ["BC"] | | Approved Prior to Jan 1, 1982 | Yes | Yes | Yes | RX | KING PHARMACEUTICALS LLC | 4eb7bdc03c765c6004af1178bc848e354df2cd9b2b27c5676a85106a58c9280f |
| 8303 | N | 050131 | 001 | PENICILLIN G BENZATHINE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | BICILLIN L-A | WYETH AYERST | 300,000 UNITS/ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | WYETH AYERST LABORATORIES | cd9487a6538a95381aa1d1cb551a3aadbbec1c247a0904fbf9ad221aaff784df |
| 8304 | N | 017422 | 001 | CARMUSTINE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | BICNU | EMCURE PHARMS LTD | 100MG/VIAL | AP | ["AP"] | | Approved Prior to Jan 1, 1982 | Yes | Yes | Yes | RX | EMCURE PHARMACEUTICALS LTD | c98a690a230b7b16986aff3c08a37aca9a3d09923fcfb564a9f619ddf2adab41 |
| 8305 | N | 050443 | 001 | BLEOMYCIN SULFATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | BLENOXANE | BRISTOL MYERS SQUIBB | EQ 15 UNITS BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | | [] | | Approved Prior to Jan 1, 1982 | Yes | Yes | No | DISCN | BRISTOL MYERS SQUIBB CO PHARMACEUTICAL RESEARCH INSTITUTE | 2a9a74b6c2d8aff009322709d1fccea84725681ee60b2dbdf7d415906e4aeae8 |
| 8306 | N | 050443 | 002 | BLEOMYCIN SULFATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | BLENOXANE | BRISTOL MYERS SQUIBB | EQ 30 UNITS BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | | [] | 1995-09-07 | Sep 7, 1995 | No | Yes | No | DISCN | BRISTOL MYERS SQUIBB CO PHARMACEUTICAL RESEARCH INSTITUTE | 30aa966ab4f79b21911e07713e71ec9a366671345b7e65989224e5e86b7757e6 |
| 8307 | A | 209439 | 001 | BLEOMYCIN SULFATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | BLEOMYCIN SULFATE | CIPLA | EQ 15 UNITS BASE/VIAL | AP | ["AP"] | 2019-03-11 | Mar 11, 2019 | No | No | No | RX | CIPLA LTD | f10d497835d8b1d4a9dbbaf76e77fb9fc9c6b158910637ff55a7f91ed91b6587 |
| 8308 | A | 065185 | 001 | BLEOMYCIN SULFATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | BLEOMYCIN SULFATE | FRESENIUS KABI USA | EQ 15 UNITS BASE/VIAL | AP | ["AP"] | 2008-01-28 | Jan 28, 2008 | No | No | Yes | RX | FRESENIUS KABI USA LLC | 82c504e013afbf65ce5fe2671ae2dcff14dec0575c7177d2f3e6756bcc7667bc |
| 8309 | A | 065185 | 002 | BLEOMYCIN SULFATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | BLEOMYCIN SULFATE | FRESENIUS KABI USA | EQ 30 UNITS BASE/VIAL | AP | ["AP"] | 2008-01-28 | Jan 28, 2008 | No | No | Yes | RX | FRESENIUS KABI USA LLC | 844e8c0859281312a30d92776ee00a625e30d0cc143879d9d5e60d6663c78afb |
| 8310 | A | 065031 | 001 | BLEOMYCIN SULFATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | BLEOMYCIN SULFATE | HOSPIRA | EQ 15 UNITS BASE/VIAL | AP | ["AP"] | 2000-03-10 | Mar 10, 2000 | No | No | No | RX | HOSPIRA INC | 78f2d6b3ab5eecbf02179889e0a42550477a2cd262d5ed5a3947352f51de3057 |
| 8311 | A | 065031 | 002 | BLEOMYCIN SULFATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | BLEOMYCIN SULFATE | HOSPIRA | EQ 30 UNITS BASE/VIAL | AP | ["AP"] | 2000-03-10 | Mar 10, 2000 | No | No | No | RX | HOSPIRA INC | 8f08f76dbd8a8ceb8972f1d928eaef25683b50fda847ccc0d8014fa53162057a |
| 8312 | A | 205030 | 001 | BLEOMYCIN SULFATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | BLEOMYCIN SULFATE | MEITHEAL | EQ 15 UNITS BASE/VIAL | AP | ["AP"] | 2018-04-20 | Apr 20, 2018 | No | No | No | RX | MEITHEAL PHARMACEUTICALS INC | aa437790a86c956919ba0f1d6e163ba1d9cc5bfcfa8848d1aba4e694b16428b5 |
| 8313 | A | 205030 | 002 | BLEOMYCIN SULFATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | BLEOMYCIN SULFATE | MEITHEAL | EQ 30 UNITS BASE/VIAL | AP | ["AP"] | 2018-04-20 | Apr 20, 2018 | No | No | No | RX | MEITHEAL PHARMACEUTICALS INC | 6366a5666c2d549a81bfabb62ced6f644e73789d99f3ddb32db426927b4a5a78 |
| 8314 | A | 065201 | 001 | BLEOMYCIN SULFATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | BLEOMYCIN SULFATE | PHARMACHEMIE BV | EQ 15 UNITS BASE/VIAL | | [] | 2007-12-13 | Dec 13, 2007 | No | No | No | DISCN | PHARMACHEMIE BV | 53895ee604e4da802c93c59276916a8badf730c43fde6983ec0f300f7b451ed6 |
| 8315 | A | 064084 | 001 | BLEOMYCIN SULFATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | BLEOMYCIN SULFATE | TEVA PARENTERAL | EQ 15 UNITS BASE/VIAL | | [] | 1996-06-01 | Jun 1, 1996 | No | No | No | DISCN | TEVA PARENTERAL MEDICINES INC | 38b15705f198dc7ff1f8e9864ffe43dc048338dfb48366bec155999917cb8b54 |
| 8316 | A | 064084 | 002 | BLEOMYCIN SULFATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | BLEOMYCIN SULFATE | TEVA PARENTERAL | EQ 30 UNITS BASE/VIAL | | [] | 1996-06-01 | Jun 1, 1996 | No | No | No | DISCN | TEVA PARENTERAL MEDICINES INC | e59ef020ec72be754e5a7694090b8530486c4fbb1ea933c1490ecb8b5188f6c4 |
| 8317 | A | 065033 | 001 | BLEOMYCIN SULFATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | BLEOMYCIN SULFATE | TEVA PHARMS USA | EQ 15 UNITS BASE/VIAL | AP | ["AP"] | 2000-06-27 | Jun 27, 2000 | No | No | No | RX | TEVA PHARMACEUTICALS USA | 0e77e92875d08a05aa32bf81bdeffa1d4b48dd5758c863c120bfb1cecda4be82 |
| 8318 | A | 065033 | 002 | BLEOMYCIN SULFATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | BLEOMYCIN SULFATE | TEVA PHARMS USA | EQ 30 UNITS BASE/VIAL | AP | ["AP"] | 2000-06-27 | Jun 27, 2000 | No | No | No | RX | TEVA PHARMACEUTICALS USA | 9f28a7f9da9955bd35f8864581f5ce741ab9b9733aa8f779e33dbd5311ab674b |
| 8319 | A | 065042 | 002 | BLEOMYCIN SULFATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | BLEOMYCIN SULFATE | WEST-WARD PHARMS INT | EQ 15 UNITS BASE/VIAL | AP | ["AP"] | 2001-10-17 | Oct 17, 2001 | No | No | No | RX | WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD | 6f43658f38a6ab9f89900a5dec2a728c0bf99cdc5880dd759e3604f373029203 |
| 8320 | A | 065042 | 001 | BLEOMYCIN SULFATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | BLEOMYCIN SULFATE | WEST-WARD PHARMS INT | EQ 30 UNITS BASE/VIAL | AP | ["AP"] | 2001-10-17 | Oct 17, 2001 | No | No | No | RX | WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD | 78b734a1f71a6607fab064adaf3759a45e4875b01433e0697946e00a2b90c8f9 |
| 8321 | N | 018678 | 001 | AMINO ACIDS | INJECTABLE;INJECTION | INJECTABLE | INJECTION | BRANCHAMIN 4% | BAXTER HLTHCARE | 4% (4GM/100ML) | | [] | 1984-09-28 | Sep 28, 1984 | No | No | No | DISCN | BAXTER HEALTHCARE CORP | 0dc3b58844733fe96b4a27d3a8d83cabc30b8c5fbb0c101f8414068f000bd9f2 |
| 8322 | N | 018684 | 001 | AMINO ACIDS | INJECTABLE;INJECTION | INJECTABLE | INJECTION | BRANCHAMIN 4% IN PLASTIC CONTAINER | BAXTER HLTHCARE | 4% (4GM/100ML) | | [] | 1984-09-28 | Sep 28, 1984 | No | No | No | DISCN | BAXTER HEALTHCARE CORP | afe67817c062d5cf9f6e30dd98f0959d1e4ea227463f6bddcb5590ad4ae6fb20 |
| 8323 | N | 018571 | 001 | TERBUTALINE SULFATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | BRETHINE | PHARMACARE | 1MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | | [] | | Approved Prior to Jan 1, 1982 | Yes | Yes | No | DISCN | PHARMACARE LTD | e8574ca8fcbbc86053fcde1b42bd72aea3b544041123cfb5b134d985995e56ce |
| 8324 | A | 070134 | 001 | BRETYLIUM TOSYLATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | BRETYLIUM TOSYLATE | ABRAXIS PHARM | 50MG/ML | | [] | 1986-04-29 | Apr 29, 1986 | No | No | No | DISCN | ABRAXIS PHARMACEUTICAL PRODUCTS | 3e268660da5ec356814af12e13a41049a5d2fc39c754c64db07c9cf72523e311 |
| 8325 | A | 071298 | 001 | BRETYLIUM TOSYLATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | BRETYLIUM TOSYLATE | ABRAXIS PHARM | 100MG/ML | | [] | 1987-02-13 | Feb 13, 1987 | No | No | No | DISCN | ABRAXIS PHARMACEUTICAL PRODUCTS | a2cb8f82b1786ef5cb56cee2d5c9d1ea670b4332a4d2abf8a7c67ff9849c85ca |
| 8326 | A | 071151 | 001 | BRETYLIUM TOSYLATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | BRETYLIUM TOSYLATE | ASTRAZENECA | 50MG/ML | | [] | 1987-08-10 | Aug 10, 1987 | No | No | No | DISCN | ASTRAZENECA LP | b95d350569d6537c2526a0dd30aaa6f85ad6469ea45a117943dc40e4e353c0f3 |
| 8327 | A | 071152 | 001 | BRETYLIUM TOSYLATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | BRETYLIUM TOSYLATE | ASTRAZENECA | 50MG/ML | | [] | 1987-08-10 | Aug 10, 1987 | No | No | No | DISCN | ASTRAZENECA LP | f07cf073aa57df24aadc735e607e59680b0a726cfecf907533274eaf953e1d13 |
| 8328 | A | 071153 | 001 | BRETYLIUM TOSYLATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | BRETYLIUM TOSYLATE | ASTRAZENECA | 50MG/ML | | [] | 1987-08-10 | Aug 10, 1987 | No | No | No | DISCN | ASTRAZENECA LP | 83f51e83b2596536b6c2b2d81bbc953b28baaa5d0427da003eb642bef6bf6727 |
| 8329 | A | 204386 | 001 | BRETYLIUM TOSYLATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | BRETYLIUM TOSYLATE | BRECKENRIDGE | 50MG/ML | | [] | 2018-12-21 | Dec 21, 2018 | No | No | Yes | RX | BRECKENRIDGE PHARMACEUTICAL INC | ddb01533134ea717de390f1c918f39fd4486295645ae5f218a63c73f98b33816 |
| 8330 | A | 070546 | 001 | BRETYLIUM TOSYLATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | BRETYLIUM TOSYLATE | EUROHLTH INTL SARL | 50MG/ML | | [] | 1986-05-14 | May 14, 1986 | No | No | No | DISCN | EUROHEALTH INTERNATIONAL SARL | 63790773ffcdbf0af5701e6b34f9d54397a822f428fe4ccafe8a7705536896d5 |
| 8331 | N | 019030 | 001 | BRETYLIUM TOSYLATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | BRETYLIUM TOSYLATE | HOSPIRA | 50MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | | [] | 1986-04-29 | Apr 29, 1986 | No | Yes | No | DISCN | HOSPIRA WORLDWIDE, INC | 6f6e06d7aed910af04e95ce738a20849c3c48eca5f89891c5b0ad47216a7bf6b |
| 8332 | N | 019033 | 001 | BRETYLIUM TOSYLATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | BRETYLIUM TOSYLATE | HOSPIRA | 50MG/ML | | [] | 1986-04-29 | Apr 29, 1986 | No | No | No | DISCN | HOSPIRA INC | 8f8b0fa76645a8cb67a6a4445376e29c7fd78d2d03d3765ae9458b3b626c2f68 |
| 8333 | A | 070119 | 001 | BRETYLIUM TOSYLATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | BRETYLIUM TOSYLATE | INTL MEDICATION | 50MG/ML | | [] | 1986-04-29 | Apr 29, 1986 | No | No | No | DISCN | INTERNATIONAL MEDICATION SYSTEM | 5bfcc1480a6c13ef24daa2cdd268e5de928efcc58873725fbb67784df6f21046 |
| 8334 | A | 070891 | 001 | BRETYLIUM TOSYLATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | BRETYLIUM TOSYLATE | LUITPOLD | 50MG/ML | | [] | 1988-07-26 | Jul 26, 1988 | No | No | No | DISCN | LUITPOLD PHARMACEUTICALS INC | 1b856f5cf0a3dde4edebf1398413584cf43ce0fad5870f68fca98ad2a9f02421 |
| 8335 | A | 070545 | 001 | BRETYLIUM TOSYLATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | BRETYLIUM TOSYLATE | WEST-WARD PHARMS INT | 50MG/ML | | [] | 1986-05-14 | May 14, 1986 | No | No | No | DISCN | WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD | 955548f4bcceca1e3d61c4f53e07722ba737efdb0edb9e6415f17e5cb6cd3c22 |
| 8336 | N | 019005 | 002 | BRETYLIUM TOSYLATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | BRETYLIUM TOSYLATE IN DEXTROSE 5% | ABBOTT | 200MG/100ML | | [] | 1986-04-29 | Apr 29, 1986 | No | No | No | DISCN | ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV | ae0ea3c030233a4c9eddddaa7547ed3ca0b5ea0a8df134ac900ae091f52eeace |
| 8337 | N | 019005 | 003 | BRETYLIUM TOSYLATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | BRETYLIUM TOSYLATE IN DEXTROSE 5% | ABBOTT | 400MG/100ML | | [] | 1986-04-29 | Apr 29, 1986 | No | No | No | DISCN | ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV | 653ea9296df331e20e07e69ab12d7ec12315407b20e398de0e005e6ffa249d28 |
| 8338 | N | 019005 | 001 | BRETYLIUM TOSYLATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | BRETYLIUM TOSYLATE IN DEXTROSE 5% | ABBOTT | 800MG/100ML | | [] | 1986-04-29 | Apr 29, 1986 | No | No | No | DISCN | ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV | 498ed2602b2fbb609e5d8d662d79411c318d8b80d29b41729d19d45e70da4995 |
| 8339 | N | 019121 | 001 | BRETYLIUM TOSYLATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | BRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINER | B BRAUN | 100MG/100ML | | [] | 1986-04-29 | Apr 29, 1986 | No | No | No | DISCN | B BRAUN MEDICAL INC | 4e7ffb3369cd4895307dc0d3d26191922c8ef1ecba75d351a05a0362d4196c78 |
| 8340 | N | 019121 | 002 | BRETYLIUM TOSYLATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | BRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINER | B BRAUN | 200MG/100ML | | [] | 1986-04-29 | Apr 29, 1986 | No | No | No | DISCN | B BRAUN MEDICAL INC | f6202e15f8ee4122e75538458c74e9f45a87ec256182dfa5dfec2da94b57f271 |
| 8341 | N | 019121 | 003 | BRETYLIUM TOSYLATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | BRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINER | B BRAUN | 400MG/100ML | | [] | 1986-04-29 | Apr 29, 1986 | No | No | No | DISCN | B BRAUN MEDICAL INC | d2e2a3d5f13d30d1c6648a6c6e31519474bbfe0015a64acbe302bf3790775b75 |
| 8342 | N | 019837 | 002 | BRETYLIUM TOSYLATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | BRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINER | BAXTER HLTHCARE | 200MG/100ML | | [] | 1989-04-12 | Apr 12, 1989 | No | No | No | DISCN | BAXTER HEALTHCARE CORP | 7da4f2573296e6227fa6f9dad044755ce9cc883732aa55017bce8e49f74ed5cd |
| 8343 | N | 019837 | 001 | BRETYLIUM TOSYLATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | BRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINER | BAXTER HLTHCARE | 400MG/100ML | | [] | 1989-04-12 | Apr 12, 1989 | No | No | No | DISCN | BAXTER HEALTHCARE CORP | 52fa4d4ee358b9bafa0758f2bec54f2da54d0117c39374579b6df2237e270030 |
| 8344 | N | 019008 | 002 | BRETYLIUM TOSYLATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | BRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINER | HOSPIRA INC | 200MG/100ML | | [] | 1986-04-29 | Apr 29, 1986 | No | No | No | DISCN | HOSPIRA INC | 4071b348360dd1f82cb93266739f2fa1d4129d89baec80d3c230075457cbf155 |
| 8345 | N | 019008 | 003 | BRETYLIUM TOSYLATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | BRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINER | HOSPIRA INC | 400MG/100ML | | [] | 1986-04-29 | Apr 29, 1986 | No | No | No | DISCN | HOSPIRA INC | 2286fcc0e838fc6239a8f12001cd6ef1c741c2e789759d054f313c68b51136f5 |
| 8346 | N | 019008 | 001 | BRETYLIUM TOSYLATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | BRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINER | HOSPIRA INC | 800MG/100ML | | [] | 1986-04-29 | Apr 29, 1986 | No | No | No | DISCN | HOSPIRA INC | 4b4aab4ac5d404c84b08c3793aaf61ad5a8180fa74f303983958b853d06e136b |
| 8347 | N | 017954 | 001 | BRETYLIUM TOSYLATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | BRETYLOL | HOSPIRA | 50MG/ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | HOSPIRA INC | 84b4baffe75f18c7c966f4d2a97591f02e4984bcfa411e77199789a6ac32698f |
| 8348 | N | 019386 | 003 | ESMOLOL HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | BREVIBLOC | BAXTER HLTHCARE | 10MG/ML | | [] | 1988-08-15 | Aug 15, 1988 | No | No | No | DISCN | BAXTER HEALTHCARE CORP | d2215a45edcf160379f73fae51dca50fe2451a6320a2dabdfb76102e3b6b74ed |
| 8349 | N | 019386 | 006 | ESMOLOL HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | BREVIBLOC | BAXTER HLTHCARE | 10MG/ML | AP | ["AP"] | 2003-02-25 | Feb 25, 2003 | No | Yes | Yes | RX | BAXTER HEALTHCARE CORP | b3137e7752da18abd1e688f7e36a1272a760fa5e9c7b172e70b0f468e931cc0b |
| 8350 | N | 019386 | 007 | ESMOLOL HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | BREVIBLOC | BAXTER HLTHCARE | 20MG/ML | | [] | 2003-05-28 | May 28, 2003 | No | No | No | DISCN | BAXTER HEALTHCARE CORP | 109bec0aa268406c3bc9c69147c013ca0685048553fc971dc669eef6bbcf9a87 |
| 8351 | N | 019386 | 005 | ESMOLOL HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | BREVIBLOC DOUBLE STRENGTH IN PLASTIC CONTAINER | BAXTER HLTHCARE | 2GM/100ML | | [] | 2003-01-27 | Jan 27, 2003 | No | Yes | Yes | RX | BAXTER HEALTHCARE CORP | 2def18932c0bdb4f379b1f97159627c745784fd38553f2b00d5416fb62afb4a4 |